European Commissioner for Internal Market Thierry Breton said that the Russian vaccine against COVID-19 Sputnik V, if approved by the European Medicines Agency (EMA), may not be available in the EU until the end of this year.
“I don’t think that the required number of doses of the Russian drug will be available in Europe by the end of 2021,” Le Figaro quotes him as saying.
Breton noted that, as with any vaccine, the first step is to test the EMA. He stressed that the agency is an independent organization. In addition, according to him, the EU regulator should study the drug dossier in the near future.
The European Commissioner did not rule out that the process of evaluating the vaccine against coronavirus by the regulator may be delayed. According to him, this is due to “lack of data.”
“The Russian Federation is looking for industrial partners in the EU countries, but they are currently involved in the production of already approved drugs,” Breton also said.
The European Union can purchase the Russian vaccine when it is tested. Recall that the examination procedure at the European Medicines Agency (EMA), which approves vaccines for use in the European market, the Russian drug “Sputnik V” has been under way since March 4.